ALS Association Announces Drug Development Contract Grant Program

ALS Association Announces Drug Development Contract Grant Program

The ALS Association has announced its new Translational Research Advancing Therapy for ALS (TREAT ALS) Drug Development Contract grant program, which will fund research for the development of new treatments for amyotrophic lateral sclerosis (ALS). According to a press release, the program will support research from early target identification…

Discussing Overactive Neurons and ALS

A recent paper from French researchers questions one of the primary ideas about what causes amyotrophic lateral sclerosis (ALS), and proposes that overactive nervous system cells are not a primary cause of the neurodegenerative disease. The paper, titled “Is hyperexcitability really guilty in amyotrophic lateral sclerosis?” appeared in…

Keeping Up With Keith: Introduction

Keith talks about amyotrophic lateral sclerosis (ALS) and his own experience with the disease and explains the reasons that made him decide to keep a vlog. This is the beginning. Keep updated about ALS here: https://bit.ly/1QHMBGw…

Liz McElhinney: Faith and Hope in MND

Liz McElhinney,  former social worker and an ordained minister in the Church of Ireland, talks about the role of faith in her experience with motor neurone disease. Read about amyotrophic lateral sclerosis and keep updated on all the latest news https://bit.ly/1QHMBGw…

Gene Mutations in Non-Familial ALS

According to a July 2014 report in the Morbidity and Mortality Weekly Report (MMWR), amytrophic lateral sclerosis (ALS) or Lou Gehrig’s disease is estimated to affect about 3.9 individuals for every 100,000 Americans, most commonly diagnosed in the elderly who are in their 70s. While…

Veterans More Likely to Develop ALS

video platformvideo managementvideo solutionsvideo player Get to know a bit about the stories of some military veterans who suffer from amyotrophic lateral sclerosis (ALS) in this video from WDBJ7 News. Read more on ALS and keep updated on al the latest news here: https://bit.ly/1QHMBGw…